Fuller & Thaler Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Fuller & Thaler Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,021	Closed	-$96K	–	563
2021 Q2	$96K	Hold	1,021	–	–	﹤0.01%	446
2021 Q1	$94K	Sell	1,021 -41,243	-98%	-$3.48M	﹤0.01%	447
2020 Q4	$3.09M	Sell	42,264 -60	-0.1%	-$4.46K	0.03%	276
2020 Q3	$3.29M	Sell	42,324 -201,304	-83%	-$13.9M	0.04%	253
2020 Q2	$13.5M	Sell	243,628 -800,893	-77%	-$34.3M	0.18%	139
2020 Q1	$30.9M	Sell	1,044,521 -62,517	-6%	-$2.12M	0.52%	71
2019 Q4	$40.1M	Buy	1,107,038 +44,348	+4%	+$1.36M	0.45%	81
2019 Q3	$28.9M	Buy	1,062,690 +375,407	+55%	+$9.71M	0.34%	96
2019 Q2	$16.5M	Buy	+687,283	New	+$17.4M	0.19%	129
2016 Q1	–	Sell	-64,300	Closed	-$1.39M	–	916
2015 Q4	$1.39M	Sell	64,300 -192,540	-75%	-$3.75M	0.03%	225
2015 Q3	$5.09M	Buy	256,840 +7,300	+3%	+$231K	0.13%	118
2015 Q2	$8.67M	Sell	249,540 -32,000	-11%	-$977K	0.25%	94
2015 Q1	$7.31M	Buy	+281,540	New	+$5.16M	0.23%	92
2014 Q3	–	Sell	-286,493	Closed	-$4.53M	–	735
2014 Q2	$4.53M	Sell	286,493 -113,028	-28%	-$1.61M	0.19%	145
2014 Q1	$6.04M	Sell	399,521 -158,600	-28%	-$1.79M	0.29%	116
2013 Q4	$4.25M	Buy	+558,121	New	+$3.01M	0.23%	150

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fuller & Thaler Asset Management's HZNP Position: Q3 2021 in Review

Fuller & Thaler Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2021, closing a stake of 1,021 shares — an estimated $96K sold.

Fuller & Thaler Asset Management first reported a position in HZNP in Q4 2013 and held it in 16 quarters. The position peaked at $40.1M in Q4 2019. 572 funds tracked by Wall St. Rank hold HZNP as of Q3 2021.

Fuller & Thaler Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2021 after selling out during the quarter.
Fuller & Thaler Asset Management sold 1,021 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2021, an estimated $96K.
Fuller & Thaler Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 16 quarters.
Fuller & Thaler Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $40.1M in Q4 2019.
572 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2021.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.